1. Bisphosphonates: effects on osteoblast

   • Nicola Maruotti
   • Addolorata Corrado
   • Francesco Paolo Cantatore

   Review Article 09 February 2012 Pages: 1013 - 1018

2. TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials

   • M. Boyce
   • M. Walther
   • S. Warrington

   Clinical Trial Open access 17 February 2012 Pages: 1019 - 1024

   

3. Influence of real-time Bayesian forecasting of pharmacokinetic parameters on the precision of a rocuronium target-controlled infusion

   • Cyrus Motamed
   • Jean-Michel Devys
   • Valérie Billard

   Pharmacodynamics 19 February 2012 Pages: 1025 - 1031

   

4. Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A>T and the losartan metabolism phenotype in Swedes

   • Fazleen H. M. Hatta
   • Lay Kek Teh
   • Leif Bertilsson

   Pharmacogenetics 01 February 2012 Pages: 1033 - 1042

   

5. Differences in lercanidipine systemic exposure when administered according to labelling: in fasting state and 15 minutes before food intake

   • Covadonga Álvarez
   • Estrella Gómez
   • Alfredo García-Arieta

   Pharmacokinetics and Disposition 01 February 2012 Pages: 1043 - 1047

6. Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

   • Teddy Kosoglou
   • Walter K. Kraft
   • David L. Cutler

   Pharmacokinetics and Disposition 08 February 2012 Pages: 1049 - 1056

   

7. Adverse drug reactions: Analysis of spontaneous reporting system in Europe in 2007–2009

   • Jindrich Srba
   • Veronika Descikova
   • Jiri Vlcek

   Pharmacoepidemiology and Prescription 01 February 2012 Pages: 1057 - 1063

   

8. Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres

   • Mira Harrison-Woolrych
   • Linda Härmark
   • Kees van Grootheest

   Pharmacoepidemiology and Prescription 08 February 2012 Pages: 1065 - 1072

9. Unlicensed and off-label drug use in hospitalized children in Croatia: a cross-sectional survey

   • Goran Palčevski
   • Nataša Skočibušić
   • Vera Vlahović-Palčevski

   Pharmacoepidemiology and Prescription 04 February 2012 Pages: 1073 - 1077

   

10. Pharmacovigilance in children in Camagüey Province, Cuba

    • Z. Bárzaga Arencibia
    • A. López Leyva
    • I. Choonara

    Pharmacoepidemiology and Prescription Open access 08 February 2012 Pages: 1079 - 1084

11. Inappropriate prescribing for the elderly—a modern epidemic?

    • Gunhild Nyborg
    • Jørund Straand
    • Mette Brekke

    Pharmacoepidemiology and Prescription 15 February 2012 Pages: 1085 - 1094

    

12. Association between multi-dose drug dispensing and drug treatment changes

    • Christina Sjöberg
    • Henrik Ohlsson
    • Susanna M Wallerstedt

    Pharmacoepidemiology and Prescription 04 February 2012 Pages: 1095 - 1101

    

13. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database

    • Solène Taugourdeau-Raymond
    • F. Rouby
    • the French Network of the Pharmacovigilance Centers

    Pharmacoepidemiology and Prescription 16 February 2012 Pages: 1103 - 1107

14. Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study

    • Leena K. Saastamoinen
    • Mika Wallin
    • J. Simon Bell

    Pharmacoepidemiology and Prescription 12 February 2012 Pages: 1109 - 1117

15. Comparative adherence to oxybutynin or tolterodine among older patients

    • Angus Thompson

    Letter to the Editors 15 February 2012 Pages: 1119 - 1119

16. Comparative adherence to oxybutynin or tolterodine among older patients

    • Tara Gomes
    • David Juurlink
    • Muhammad Mamdani

    Letter to the Editors 08 February 2012 Pages: 1121 - 1121